Artificial pancreas effectively controls type 1 diabetes in children age 6 and up - دانشمندان با استفاده از لوزالمعده مصنوعی توانستند دیابت کودکان را با موفقیت درمان کنند

A clinical trial at four pediatric diabetes centers in the United States has found that a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — is safe and effective at managing blood glucose levels in children as young as age six with type 1 diabetes.

Results from the trial were published August 26 in the New England Journal of Medicine.

Release date: 26 August 2020

Source: NIH/National Institute of Diabetes and Digestive and Kidney Diseases